Non PVC IV Bags Market

Global Non PVC IV Bags Market Size (2023 to 2028)

The Global non pvc iv bags market is expected to grow from USD 2.11 billion in 2023 to USD 3.76 billion by 2028, growing at a CAGR of 12.24% from 2023 to 2028

Global Non PVC IV Bags Market Share Insights:

• Based on type, the multichambered segment held the major share of the global market in 2022.
• Based on material, the ethylene vinyl acetate segment led the market in 2022.
• Based on application, the chemotherapy segment was the largest segment in the global market in 2022.
• Geographically, the North American region captured the biggest share of the global market in 2022.

Impact of Covid-19 on the non-PVC IV bags Market:

Before arising of the pandemic crisis, the healthcare sector shifted its focus towards wellness and population health which depend upon invasive procedures and treatment, key players were focused on growth strategies for product approval in the global non-pvc iv bags market, but after arise of the global pandemic crisis, several countries faced economic challenges, also there was a large strain on the healthcare sector due to scarcity of manpower, equipment and other resources which required to ensure safety in hospital and provide treatment to a patient with other diseases, which has significantly impacted the non-PVC IV bags market. Patients affected by the novel coronavirus require hospitalization, where bags are used to deliver medication to the patient which increases the demand for non-pvc iv bags, the post-pandemic situation demands more non-pvc iv bags which is anticipated to propel the market growth in the upcoming years.

MARKET DRIVERS:

One of the key factors propelling the non PVC IV bags market is the rising prevalence of cancer. The rising prevalence of cancer requires appropriate medication such as chemotherapy which involves administration of medication orally or through an intravenous route, according to the WHO, cancer is the leading cause of death in the globe. In 2022 globally there were 2.1 million new cases of cancer arising worldwide, chemotherapy, radiotherapy, and surgical procedures are the cancer treatment used to treat the patient. According to a study, the patient who requires chemotherapy will increase from 11.2 million to 13.3 million between 2023 t0 2028, the increase in chemotherapy will tremendously increase the adoption of non-pvc bags, these bags made of ethylene vinyl-acetate and polypropylene, cancer treatment can lead to deprivation of nutrition through non-PVC iv bags, which allow the global market growth in the upcoming years.

The growing awareness among the population regarding the usage of non-pvc iv bags is the second major factor fuelling the growth of the market. Non-pvc IV bags are typically free from plasticizers, which has no environmental effect, and this is a safer option for both patient and medical staff, this lead to rising the adoption of non-pvc iv bags, which boosts the market growth during the forecast period. Increasing healthcare expenditure and rising research and development activities is the third major factor favoring market growth. the rising healthcare expenditure are way to optimize costs while maintaining quality care, these bags have higher cost and also offer long-term benefits by reducing the risk associated with PVC bags and supporting patient safety, the emphasis on quality care and patient safety aligns with the adoption of the non-pvc iv bags, leading to increased their usage, the rising research and development activities leads to the innovate and improve medical products, which include development of safer, more effective and environmentally friendly products such as non-pvc iv bags, which boost the market growth during the projected period.

The other factor propelling the growth of the market is the increasing product launches by key player, rising research and developmental activities, rising prevalence of cancer, and increasing awareness among the population majorly boosting the market growth during the forecast period.

MARKET RESTRAINTS:

The high cost associated with non-PVC IV bags and stringent government regulatory policies is the major obstacle hampering the market growth in the upcoming years. Non-pvc IV bags come with a higher initial cost, while these bags offer long-term benefits in terms of patient safety and environmental impact, the investment in these bags can be a challenge for some healthcare providers, also the stringent regulatory condition and policies are time-consuming and complex processes, which can delay the introduction of new medical products such as non-pvc iv bags, hence this two factor majorly hinder the market growth during the forecast period.

REPORT COVERAGE:

This research report on the global Non-PVC IV bags Market has been segmented and sub-segmented based on the Type, material, Application, and Region.

Non-PVC IV bags Market- Based on Type

• Single-chambered
• Multi-chambered

Based on type, the multichambered segment is anticipated to drive market growth during the projected period. It is possible to separate various drugs, ingredients, or solutions into separate chambers using multichambered IV bags. The stability of each drug up to the moment of administration is guaranteed by this segmentation, which helps prevent interactions between incompatible substances. When giving a patient various medications, this functionality is particularly important. Multichambered bags' separate chambers reduce the possibility of cross-contamination between various drugs or fluids. This is crucial when working with compounds that should never interact, such as delicate or dangerous ones, as there are more benefits associated with multichambered non-pvc IV bags, propelling the market growth in the upcoming years.

The single-chambered segment is also predicted to hold a significant market share during the projected period. Single-chambered IV bags are simple to use and understand. They are a practical option for healthcare practitioners who don't need to deal with complicated mixing or several compartments because they are perfect for situations where only one medication or solution needs to be supplied, hence this segment also propels the market growth during the forecast period.

Non-PVC IV bags Market- Based on Material

• Non-PVC IV bags Market- Based on Material
• Polypropylene (PP) IV Bag
• Polyethylene IV Bag
• Copolyester Ether IV Bag
• Ethylene-vinyl Acetate (EVA) IV Bag
• Others

Based on material, the ethylene vinyl acetate segment held the largest market share of around 34.28% in 2022 and is anticipated to account for a notable market share during the projected period. This material widely used for PVC alternatives, in blood banks, and for the storage of frozen mixtures, this material is widely used, growing recognition and high demand for blood component storage as a result of an increase in the number of blood banks are the factor driving the significant market share during the forecast period. With the increased understanding and awareness of parenteral nutrition therapy and the high prevalence of chronic disease, globally 1.9 million suffer from chronic disorders which need non-pvc IV bags, driving the segmental growth and boosting the market in the upcoming years.

The copolyester ether segment is also projected to exhibit the fastest growth in the market during the forecast period. Copolyester ether has several advantages, including strength, transparency, chemical resistance, and resistance to a range of sterilizing techniques, including autoclave, radiation, and electron beam. In the history of copolyester ether in pharmaceutical packaging, the invention of Ecdel elastomer has proven to be a turning point.

Among the businesses creating these pairings are Abbott Laboratories, Sealed Air Corporation, B. Braun Melsungen AG, and Eastman Chemical Company. This drives segmental growth and boosts the market during the projected period.

Non-PVC IV Bags Market- Based on Application

• Chemotherapy
• targeted Drug Delivery
• Glucose Injection
• Sodium Chloride Solution
• Electrolyte Injection
• Nutrient Injection

Based on application, the chemotherapy segment is expected to hold a 46.8% market share in the global market during the projected period. The rising prevalence of cancer requires appropriate medication such as chemotherapy which involves the administration of medication orally or through an intravenous route, According to a study, the patient who requires chemotherapy will increase from 11.2 million to 13.3 million between 2023 t0 2028, the increase chemotherapy will tremendously increase the adoption of the non-pvc bags, these bags are made of ethylene vinyl acetate, which used for the treatment of oncology, which allows the segmental and global market growth in the upcoming years.

The glucose injection segment is also anticipated to hold a substantial market share in the upcoming years. For a variety of medical uses, glucose injectable solutions are frequently utilized in healthcare settings. They are frequently used as a source of energy for individuals who are unable to consume oral food or drinks as well as intravenous hydration and nutritional support, this medication requires non-pvc IV bags, which propel the segmental growth and boost the market in the upcoming years.

Non-PVC IV bags Market- Based on Region

• North America
• Latin America
• Europe
• Asia-Pacific
• Middle East and Africa

Geographically, the North-America region captured about 47.8% share in 2022 and is anticipated to grow at a CAGR of 12.5% during the projected period. As the incidence of stomach cancer has grown over the past few years, so too has the demand for IV bags. For instance, according to the American Cancer Society, there will be 29,800 new cases of stomach cancer diagnosed in the United States in 2022, which implies that 14,010 patients will pass away from the disease. Stomach cancer patients are unable to swallow food, thus they must fully rely on total parenteral nutrition to meet their nutritional needs and ensure their life, which surges the demand for these bags, and boost the market growth. The increasing adoption of novel drug delivery systems and innovation in the technology are anticipated to fuel the market growth in this region.

APAC is the second-largest region expected to show lucrative growth in the market and grow at the highest CAGR during the forecast period. As numerous countries in the APAC region invest in their healthcare infrastructure, they might give non-PVC IV bags and other safer, more advanced medical equipment the greatest importance, including an increase in the number of hospitals, clinics, and blood banks, these are all factors that are significantly influencing the industry's expansion in this region and propel the market growth.

Europe region is predicted to grow at a healthy CAGR and hold a significant market share during the forecast period. Patient safety, product quality, and environmental sustainability are all highly prioritized in Europe's regulatory framework. The European Medicines Agency (EMA) and other regulatory organizations support the use of medical devices that are less hazardous and less harmful to the environment, such as non-PVC IV bags. Manufacturers are motivated to create and promote these products by European standards by this legislative backing. Patient safety and high-quality care are given top priority in European healthcare systems. This emphasis is well-aligned with non-PVC IV bags, which are thought to be safer due to lower risks of plasticizers leaching. European healthcare institutions and personnel are more inclined to use products that improve patient safety.

Latin America region is also anticipated to grow at a steady CAGR during the projected period. The market for non-PVC IV bags will benefit as healthcare systems and knowledge in these areas continue to advance. This will encourage the adoption of safer and more environmentally friendly medical solutions.

The Middle East and Africa region also holds a notable share of the market during the forecast period.

KEY MARKET PLAYERS:

The prominent key player in the global non pvc iv bags market are Renolit SE, Kraton Corporation, Shanghai Solve Care Co., Ltd., Shanghai Xin Gen Eco-Technologies Co., Ltd., PolyCine GmbH, Jiangxi Sanxin Medtec Co., Ltd., Sealed Air, Baxter, B. Braun Melsungen AG, Sichuan Kelun Pharmaceutical Co., Ltd., Fresenius Kabi AG, Otsuka Holdings Co., Ltd., Sartorius AG, Technoflex, and Huaren Pharmaceutical Co., Ltd.

RECENT MARKET DEVELOPMENTS:

• In June 2022, High-quality Dual Chamber bags made of polypropylene (DEHP free) with a peelable aluminium foil were introduced by Gufic Biosciences, allowing the storage of unstable medications that require reconstitution immediately before being administered to patients.
• In April 2022, In the US, Fresenius Kabi introduced Calcium Gluconate in Sodium Chloride Injection in ready-to-use freeflex bags. The polyolefin used in the freeflex packets is non-PVC and free of the plasticizer Di-ethylhexyl-phthalate (DEHP).